Company profile

Ammunition company profile

Ammunition is a biotech company that creates technology for early cancer detection with a focus on endometrial, colorectal, cervical, and esophageal cancer. To help clinicians effectively detect, diagnose, and treat early cancer, the firm conducts research and develops early cancer detection technologies using epigenetics, nanomaterials, bioinformatics, big data technology, and artificial intelligence analysis.

Business identity

Contact email
[email protected]
Phone number
400-1024-253
Operating status
Active
Company type
For Profit
Revenue range
$1K+
Founded
2015-01-01

Headquarters

Headquarters
Wuhan, Hubei, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Last funding
Series B / 2021-02-02
Last equity funding
Series B
Investors
3
Lead investors
1
Articles
1

Founders and investors

Lead investors

JinHe Ziben

Investors

Changjiang SecuritiesGuangdong Hybribio BiotechJinHe Ziben

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.